Author: Minichart

us corporate news

AN2 Therapeutics Secures $40 Million in Private Placement Financing to Advance Boron-Based Drug Pipeline

Minichart

March 10, 2026

AN2 Therapeutics Announces \$40 Million Private Placement Fi...

Continue Reading 0

us corporate news

UWM Holdings Corporation Files Form 8-K with SEC – Key Company Information and Regulatory Details (March 9, 2026)

Minichart

March 10, 2026

UWM Holdings Corporation Issues Update Ahead of Two Harbors ...

Continue Reading 0

us corporate news

Aclaris Therapeutics, Inc. 8-K SEC Filing Summary – Company Information & Details (March 9, 2026)

Minichart

March 10, 2026

Aclaris Therapeutics, Inc. Raises \$39.8 Million in Common S...

Continue Reading 0

us corporate news

Playtika Appoints Tae Lee as Acting Chief Financial Officer Effective April 1, 2026 5

Minichart

March 10, 2026

Playtika Holding Corp. Executive Changes: Details for Invest...

Continue Reading 0

us corporate news

Elevance Health, Inc. Files Form 8-K with SEC on March 10, 2026 – Company Information and Compliance Details

Minichart

March 10, 2026

Elevance Health, Inc. Reaffirms 2026 Earnings Guidance Amid ...

Continue Reading 0

us corporate news

Trio Petroleum Corp Files Form 8-K for Common Stock (TPET) Listing on NYSE American – Company Details and Legal Opinion Included

Minichart

March 10, 2026

Trio Petroleum Corp Files Form 8-K: Updates on At Market Iss...

Continue Reading 0

us corporate news

Lipocine Announces 2025 Financial Results and Progress on Postpartum Depression, Epilepsy, and Obesity Drug Pipeline

Minichart

March 10, 2026

Lipocine Inc. Reports Full-Year 2025 Financial Results and P...

Continue Reading 0

us corporate news

TransUnion Unveils AI-Driven Growth Strategy and Reintroduces Financial Targets at 2026 Investor Day

Minichart

March 10, 2026

TransUnion Investor Day 2026: Key Highlights and Shareholder...

Continue Reading 0

us corporate news

Walker & Dunlop Investor Day 2026: Strategic Growth Targets, Market Leadership, and Financial Outlook in Commercial Real Estate Capital Markets

Minichart

March 10, 2026

Walker & Dunlop Investor Day 2026: Strategic Vision, Financi...

Continue Reading 0

us corporate news

Zura Bio’s Tibulizumab: First-in-Class Bispecific Antibody Targeting IL-17 and BAFF for Autoimmune Diseases (HS & SSc) – Pipeline, Trials, and Market Opportunity 2348

Minichart

March 10, 2026

Zura Bio Ltd. Corporate Update: Advancing Tibulizumab, a Fir...

Continue Reading 0